Details of the Drug
General Information of Drug (ID: DMXPFYZ)
Drug Name |
2-fluorophenylboronic acid
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
2-Fluorophenylboronic acid; 1993-03-9; (2-fluorophenyl)boronic acid; 2-Fluorobenzeneboronic Acid; (2-fluorophenyl)boranediol; Boronic acid, B-(2-fluorophenyl)-; o-fluorophenylboronic acid; 2-fluorophenyl boronic acid; 2-fluoro-phenyl-boronic acid; BORONIC ACID, (2-FLUOROPHENYL)-; MFCD00674013; 2-Fluorophenylboronic acid, 98%; 34-03-7; PubChem1856; 2-Fluorophenylboronicacid; o-fluorobenzeneboronic acid; ACMC-1BR1I; o -Fluorophenylboronic acid; 2-fluoro-phenylboronic acid; AC1MC0Y0; 2-fluoro phenylboronic acid
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 |
Molecular Weight | 139.92 | |||||||||||||||||||||
Logarithm of the Partition Coefficient | Not Available | ||||||||||||||||||||||
Rotatable Bond Count | 1 | ||||||||||||||||||||||
Hydrogen Bond Donor Count | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count | 3 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||